452 related items for PubMed ID: 31139951
1. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
[Abstract] [Full Text] [Related]
2. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[Abstract] [Full Text] [Related]
3. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
Edraki MR, Mohammadi H, Mehdizadegan N, Ghorashi M, Amoozgar H, Borzouee M, Ajami G, Keshavarz K, Dehghani E, Bahrami R.
Arch Iran Med; 2020 Jan 01; 23(1):31-36. PubMed ID: 31910632
[Abstract] [Full Text] [Related]
4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Jan 01; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
5. Usefulness of Kawasaki disease risk scoring systems to the Turkish population.
Öztarhan K, Varlı YZ, Aktay Ayaz N.
Anatol J Cardiol; 2020 Aug 01; 24(2):97-106. PubMed ID: 32749248
[Abstract] [Full Text] [Related]
6. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
Rheumatol Int; 2016 Jul 01; 36(7):905-10. PubMed ID: 27215220
[Abstract] [Full Text] [Related]
7. Comparison of IVIG resistance predictive models in Kawasaki disease.
Kaya Akca U, Arslanoglu Aydin E, Aykan HH, Serin O, Sag E, Demir S, Atalay E, Kasap M, Batu ED, Karagoz T, Bilginer Y, Ozen S.
Pediatr Res; 2022 Feb 01; 91(3):621-626. PubMed ID: 33753891
[Abstract] [Full Text] [Related]
8. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S.
PLoS One; 2017 Feb 01; 12(5):e0176957. PubMed ID: 28542183
[Abstract] [Full Text] [Related]
9. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 01; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
10. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
Huang CN, Wu FF, Chang YM, Huang HC, Lin MT, Wang JK, Wu MH.
J Formos Med Assoc; 2021 Oct 01; 120(10):1884-1889. PubMed ID: 33358267
[Abstract] [Full Text] [Related]
11. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
Kardiol Pol; 2017 Oct 01; 75(3):261-266. PubMed ID: 27995598
[Abstract] [Full Text] [Related]
12. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
Wang Z, Xu Y, Zhou H, Wang Y, Li W, Lu Z, Jiang Z, Gu X, Zheng H, Zeng L, Huang P, Zhang L, Gu X.
Cardiovasc Ther; 2020 Oct 01; 2020():3568608. PubMed ID: 32256707
[Abstract] [Full Text] [Related]
13. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
Am J Ther; 2016 Oct 01; 23(6):e1293-e1299. PubMed ID: 25611359
[Abstract] [Full Text] [Related]
14. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 01; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
15. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
Kanamitsu K, Kakimoto H, Shimada A, Nakata Y, Ochi H, Watanabe H, Iwasaki Y, Tokorodani C, Kanazawa A, Maruyama H, Miyazawa M, Nishiuchi R, Kikkawa K.
Pediatr Int; 2016 Feb 01; 58(2):146-51. PubMed ID: 26190225
[Abstract] [Full Text] [Related]
16. Neurological involvement in Kawasaki disease: a retrospective study.
Liu X, Zhou K, Hua Y, Wu M, Liu L, Shao S, Wang C.
Pediatr Rheumatol Online J; 2020 Jul 14; 18(1):61. PubMed ID: 32664982
[Abstract] [Full Text] [Related]
17. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
Shin J, Lee H, Eun L.
J Korean Med Sci; 2017 Dec 14; 32(12):1991-1996. PubMed ID: 29115081
[Abstract] [Full Text] [Related]
18. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
Cardiology; 2023 Dec 14; 148(5):457-468. PubMed ID: 37231847
[Abstract] [Full Text] [Related]
19. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
[Abstract] [Full Text] [Related]
20. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 15; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
